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Sunlight is the principal aetiological factor associated with skin cancer development. However, 
genetic and phenotypic factors also contribute to skin cancer risk. In this study, we deeply 
sequenced 46 cancer genes in normal skin biopsies from 127 healthy donors. Our results reveal 
an exponential accumulation of UV-related somatic mutations with age, matching skin cancer 
incidence. The increase of mutational burden is in turn modified by an individual’s skin 
phototype. Somatic mutations preferentially accumulated in cSCC driver genes and clonally 
expanded with age, with distinct mutational processes underpinning different age groups. Our 
findings reveal that aged, sun-exposed normal skin is an extended mosaic of multiple clones 
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This study delineates how somatic mutations accumulate in sun-exposed normal skin from 
different age and skin phototype groups. Having a large cohort has allowed us to explore the 
effect of well-known intrinsic and extrinsic factors in the mutational burden of normal skin. 
Apart from age, an individual’s skin phototype is key in the build-up of somatic mutations in 
healthy skin, playing a more significant role than the history or the body site pattern of sun 
exposure. This could be of vital value for the development of specific clinical strategies to 
manage patients with increased risk of skin cancer. Additionally, our results highlight the 
importance of discriminating clones with tumorigenic potential from benign clones with 






All cancers arise as a result of somatic alterations occurring in the genomic DNA sequence of 
‘normal’ cells. Somatic genomic alterations accumulate spontaneously in cells throughout a 
person's life as a result of errors occurring during cell replication or after exposure to mutagenic 
agents, such as certain chemicals in tobacco smoke or UV radiation from sunlight (Martincorena 
and Campbell, 2015; Stratton et al., 2009). 
 
The accumulation of clones of cells harbouring mutations across tissues may be expected to 
have functional consequences to the physiology of normal cells, contributing to ageing and 
promoting disease progress, as in the case of cancer. In this regard, recent sequencing studies 
have revealed that, in general, the somatic mutational burden and profile of physiological 
normal tissues seem to be relatively similar to those found in tumours from the same tissue 
(Brunner et al., 2019; Jaiswal et al., 2014; Lee-Six et al., 2019; Martincorena, 2019). These 
results suggest that the majority of somatic alterations may appear randomly, pre-dating 
tumours, and only a small fraction of all somatic mutations in a cancer genome are, therefore, 
relevant in carcinogenesis, disease classification and treatment. 
 
In the case of skin, a recent study analysing cancer-free epidermal samples from four 
individuals showed that the frequency of driver mutations in physiologically normal skin cells is 
surprisingly high (Martincorena et al., 2015). Sun-exposed epidermal cells carried a multitude 
of genetic alterations, and about 25-30% of these normal skin cells had already acquired at least 
one driver mutation, indicating that cancer-causing mutations are under strong positive selection 
even in epidermis maintaining normal physiological functions. The mutational profile found in 
eyelid samples, a chronically sun-exposed area, was similar to cutaneous squamous cell 
carcinomas (SCCs), but distinct from the profile characteristically observed in cutaneous 
melanoma (Martincorena et al., 2015). This may be due to the low number of epidermal 
melanocytes (cells from which melanoma develops) in relation to keratinocytes (Hoath and 
Leahy, 2003), but also due to the fact that melanoma appears more frequently in sporadically, 
rather than chronically, sun-exposed areas of the body – those that are usually covered by 
clothing. This apparently paradoxical fact is attributable to injuries caused by an intermittent 
pattern of intense and acute sun exposure associated with recreational activities (Gandini et al., 
2005).  
 
Skin cancer incidence worldwide reveals a clear relationship between pigmentation traits and 
sunlight damage, with individuals with fair skin and inability to tan showing greater cancer 
susceptibility. Cutaneous sensitivity to sunlight exposure (ability to tan versus tendency to burn) 
is defined by certain genetically determined pigmentation traits (Scherer and Kumar, 2010). 
Thus, individuals carrying genetic variants associated with increased sun sensitivity – and with 
low skin phototype – should have higher somatic mutational rates, as they have reduced melanin 
levels, insufficient to protect the genome of epidermal cells from the mutagenic action of UV 
light (Brenner and Hearing, 2008; Rijken et al., 2004).  
 
While previous studies have confirmed that seemingly normal cells harbour mutations, the key 
factors that determine which individuals are more prone to acquire and therefore accumulate 
somatic mutations remains unclear. This is probably due to the fact that most studies have 
explored somatic alterations in a limited number of individuals. With the aim of increasing our 
understanding of the accumulation somatic mutations in the skin as a consequence of different 
patterns of sunlight exposure, we focused on sequencing skin samples from a large cohort of 
127 cancer-free individuals (Figure 1). We examined somatic mutational burdens, mutational 
signatures, clonal selection, and frequency of driver mutations in normal epidermal samples 
from chronically-, intermittently- and non-photoexposed body sites. Furthermore, we explored 
if there is an added risk to accumulate somatic mutations according to intrinsic characteristics of 
individuals (i.e. age, and pigmentation-related genotype and phenotype) and to sun exposure 





Variation of mutational burden across samples 
 
We performed an ultra-deep targeted sequencing of 46 cancer genes in normal epidermal 
samples obtained from 127 cancer-free volunteers, aged 10 to 92 years (mean of 58.07 years), 
undergoing an excision of benign cutaneous lesions. The average on-target coverage across 
samples was 953.82x (range 377.96-1657.37x). Skin samples were collected from different 
body areas, classified according to the pattern of sunlight exposure as (a) chronically-
photoexposed (n=44), (b) intermittently-photoexposed (n=79), and (c) non-photoexposed (n=4). 
Each sample was collected from one donor due to ethical reasons. The study cohort is described 
in Table S1. 
 
A total of 5,301 mutations were identified in our dataset, with an average of 41.74 mutations per 
sample (range 2-169) (Figure 2A), and at an average rate of 130.56 mutations per megabase 
(range 6.25-528.13). The mutational burden variation across samples significantly correlated 
with age (Spearman’s ρ=0.61, P-value = 2.89x10-14; Figure 2B) and pattern of body site 
photoexposure (Kruskal-Wallis test, P-value = 1.12x10-4; Figure 2C). Consistent with previous 
studies of normal tissue, most mutations were likely present only in a small fraction of cells, 
evidenced by the fact that the majority of mutations exhibited a variant allele frequency (VAF) 
lower than 5% (Figure S1D).  
 
The size of our cohort offered us a unique opportunity to directly quantify the key factors 
associated with mutational burden in sun-exposed skin samples. Indeed, several phenotypic and 
behavioural risk factors were collected from the participants, including sex, age, Fitzpatrick’s 
skin phototype, history of sunlight exposure, body site pattern of sun exposure, signs of sun 
damage in the skin area biopsied and MC1R genotype.  
 
To empirically assess the relative importance of each potential risk factor in contributing to the 
mutational burden of skin lesions, we used a log-linear multivariate model. Strikingly, the total 
variance of mutational burden explained by all variables combined was high (adjusted-R2 = 
49.88%), with age explaining the largest proportion of the total variance (55.16%; Figure 3A). 
Surprisingly, this analysis revealed that an individual’s skin phototype is the second strongest 
predictor, explaining 17.92% of the mutational burden variance across samples. Our results 
suggest a significant decrease (β < 0) in the number of somatic mutations accumulated in skin 
samples from individuals with high skin phototypes (skin types that normally tan after sunlight 
exposure), as compared with individuals with low skin phototypes (skin types that normally 
burn after sunlight exposure) (Table S2). Therefore, the ability to protect the skin against UV 
radiation plays a key role in both photoaging and likely skin cancer. This is consistent with the 
fact that people with low skin phototypes (I/II) have a tendency to develop sunburns and 
frequently lack the ability to acquire a tan following exposure to sunlight. This lack of tanning 
capacity confers greater susceptibility to develop skin cancers, due in part to the inability to 
protect against UV-related DNA damage (Scherer and Kumar, 2010).  
 
Contrary to previous studies (Robles-Espinoza et al., 2016), no association was found between 
the somatic mutational load and the genotype in the melanocortin 1 receptor (MC1R), a key 
pigmentation-related gene determining the ability to respond to UV exposure (García-Borrón et 
al., 2014). Moreover, a lack of significant association between mutational burden and the 
pattern of body site photoexposure (chronic versus intermittent) was observed after including all 
risk factors in the model, explaining only 7.82% of the variance of the total number of 
mutations accumulated across samples. Our data suggest a comparable effect of intermittent 
exposure to sunlight, perhaps while on recreational activities, and continuous exposure, through 
spending a large amount of daylight time outdoors, with regards to the accumulation of somatic 
mutations in normal epidermis. 
 
Finally, given that age and phototype were the two most significant contributors to explain 
mutational burden, we quantitatively assessed age-related mutational burden according to skin 
phototype. For each skin phototype, we determined the mutation rate increased per year of life 
using a log-linear model (Figure 3B). Nonparametric bootstraps (1000 runs) were conducted to 
estimate the 95% confidence intervals (CI95) of the age effect. Somatic accumulation rates per 
year of life in the selected genes (0.32 Mb) increased across skin phototypes, ranging from 1.07 
mutations per year for type I (6.72%, CI95: 5.86-7.68%) to 1.04 for skin phototype IV (4.17%, 
CI95: 3.28-4.76%).  
 
Taken together, these results suggest a profound influence of age on the accumulation of 
somatic mutations in normal skin. This age-associated rise of mutational burden is in turn 
modified by an individual’s skin phototype, indicating the inability of UV-sensitive individuals 
to protect against UV-related DNA damage. 
 
Aging and the rise of UV-associated mutations 
 
To explore the mutational processes underpinning the accumulation of mutations in sun-
exposed samples, we considered the specific substitution types. In the cohort as a whole, we 
observed a predominance of C>T and CC>TT mutations at dipyrimidine sites (TpC or CpC 
context), likely reflecting repair of 6,4-photoproducts and the production of cyclobutane 
pyrimidine dimers (CPDs) in response to UV-induced DNA damage (Ravanat et al., 2001) 
(Figure 4A). These C>T substitutions were preferentially accumulated on the non-transcribed to 
the transcribed strand (Poisson test, P-value = 4.21x10-4), consistent with the activity of 
transcription-coupled nucleotide excision repair (Figure 4B). In addition, we also observed an 
enrichment of T>C/A>G mutations at CTT sites, potentially caused by indirect DNA damage 
after UV radiation – greater incorporation of G, rather than A, opposite thymidine and cytidine 
photodimers by translesion polymerases (Figure 4A). This is in line with the fact that these 
mutations tended to accumulate in the transcribed rather than in the non-transcribed strand 
(Poisson test, P-value = 5.43x10-5) (Figure 4B). 
 
To quantify the presence of specific mutational signatures, which may reflect underlying 
mutational processes, we applied deconstructSigs to the combined set of mutations within the 
cohort. Non-photoexposed skin samples were discarded for signature analyses because of the 
limited number of samples and the small number of mutations. The specific mutational 
spectrum observed in our samples mainly reassembles the COSMIC base substitution signatures 
related to UV radiation (mutational signatures SBS7a-d). In fact, 44.32% of mutations could be 
attributed to the SBS7b signature, which may reflect the existence of mutational processes 
related to dipyrimidine photoproducts, with signatures SBS7c and SBS17a accounting for 
13.92% and 13.76% of mutations, respectively (Figure S2B). 
 
Remarkably, the relative contribution of UV-related mutational pathogenesis varied markedly 
with age (Figure 4C). Mutational signatures directly related to UV contributed 68.14% of all 
mutations detected after the age of 63 (the cohort median age), and only 46.59% of the 
mutational burden in individuals younger than 63 (Figure S2B). This observation is in 
accordance with the fact that non-melanoma skin tumours (BCC and cSCC) typically occur at 
advanced age and are related to cumulative sun exposure (Leiter et al., 2014). In fact, we 
observed that the increase of UV-mutations in normal skin with age follows a similar 
exponential trend than skin cancer incidence in Spain (data downloaded from the Global Cancer 
Observatory, http://gco.iarc.fr) (Figure 4D). The main difference between the elderly and 
younger individuals in terms of mutational spectra, apart from the fraction of UV-related 
mutations, was related to the fraction of T>C/A>G mutations at CTT contexts, being 
surprisingly high in younger individuals. This mutational pattern closely matched the SBS17a 
signature, a COSMIC signature with unknown aetiology that has been shown to contribute to 
cutaneous melanoma (Alexandrov et al., 2019). To gain insight into the context dependency of 
this T>C/A>G substitutions, we explored the local sequence contexts (from -5 to +5 positions) 
and observed a specific pattern of contextual preference (CTTTT) in normal skin samples 
biopsied from younger individuals (Figure S3A). Additionally, the degree of transcriptional 
strand bias detected for T>C/A>G substitutions was substantially higher in younger individuals 
(Figure S3B). These differences in the mutational spectra are mainly caused by the exponential 
increase of C>T substitutions with age, since the absolute number of T>C/A>G mutations are 
similar among age groups. These observations suggest that initially the acquisition of T>C/A>G 
substitutions in normal skin is relatively high. However, after the age of 60, the mutagenic 
process related to sunlight is the major contributor to the accumulation of somatic mutations in 
skin.  
 
To confirm that the differences shown in mutational spectra with age are not due to unequal 
sun-exposure between subgroups (the proportion of chronically-photoexposed skin samples is 
higher in the elderly group than in the young group), we implemented deconstructSigs splitting 
samples of each age group according to the pattern of sunlight exposure of the skin tissue 
biopsied. These results confirmed that the sunlight exposure of the skin sample was not a 
confounding factor in the age-specific mutational pattern observed (Figure S3C).  
 
Taken together, our results reveal that distinct mutational processes operate with age. After an 
initial accumulation at younger ages of the SBS17a signature, which seems to remain steady 
during life, UV-related mutational processes appear to cause more mutations as age progresses.  
This suggests a clear decline in the ability to repair UV induced mutagenic lesions later in life. 
 
Positive selection of driver mutations in normal skin 
 
We next considered whether protein-altering somatic mutations were subjected to positive 
selection. We evaluated the footprint of positive selection in two orthogonal ways, by 
quantifying the excess of non-synonymous mutations as well as by estimating clone size. 
 
The majority of the normal sun-exposed skin samples harboured multiple protein-altering 
mutations, even though these epidermal samples were histologically benign (Figure S4A). 
Given the significant effect of age in mutational burden observed, together with the fact that 
clonal expansions of cancer-associated mutations are extremely common with age (Risques and 
Kennedy, 2018), we examined if these mutations accumulate randomly or if there is also an 
enrichment of non-synonymous mutations with age. As expected, the number of putative driver 
mutations accumulated per sample increased with age (Wilcoxon-Mann-Whitney test, P-value = 
1.10x10-9; Figure 5A), with the non-synonymous mutational burden in samples from elderly 
individuals even higher than the one observed in cSCC (Wilcoxon-Mann-Whitney test, P-value 
= 2.40x10-5) and in cutaneous melanoma samples (Wilcoxon-Mann-Whitney test, P-value = 
2.50x10-9; Figure 5A). In addition, these non-synonymous mutations tended to accumulate in 
specific cancer-associated genes (Figure 5B). We found that the catalogue of recurrently 
mutated genes in normal skin was almost identical to that of cSCC, with TP53, NOTCH1, 
NOTCH2 and FAT1 being recurrently mutated in both normal skin and cSCC samples (Figure 
S4B). 
 
In order to quantify the extent of positive selection driving minor clonal expansion in normal 
skin samples in both elderly and young donors, we considered the ratio of missense, nonsense 
and essential splicing mutations compared to synonymous mutations using the dNdScv package. 
Our results provided evidence of significant positive selection when considering mutations in all 
cancer genes as a whole (Figure 5C) and specifically in three out of 46 sequenced genes for 
normal skin samples collected from both young and elderly individuals (TP53, NOTCH1, and 
FAT1) (Figure 5D). Notably, all three genes were also shown to have a significant excess of 
non-synonymous mutations in normal sun-exposed epidermis (Martincorena et al., 2015), and 
have been shown to be drivers of cutaneous squamous cell carcinoma (cSCC) (Inman et al., 
2018; Pickering et al., 2014).  
 
Additionally, a significant excess of truncating point mutations in NOTCH2 and CDKN2A, two 
tumour suppressor genes recurrently mutated in skin cancers (Hayward et al., 2017; Inman et 
al., 2018; Pickering et al., 2014), were also found in samples from elderly individuals. In 
addition, we identified samples with canonical hotspot mutations with therapeutic relevance 
(according to the database of curated mutations) in several oncogenes such as BRAF (V600E), 
HRAS (G12D, G12V), PIK3CA (P471L, E542K, E726K, M1043I, H1047L), and FGFR3 
(R248C, S249C, Y373C, A391E). In total, forty-two donors (81% of them older than 63 years) 
in our cohort carried at least one of the 50 different relevant disease-causing mutations 
identified.  
 
In order to confirm whether these protein-altering mutations are exerting a selective pressure for 
clonal expansion, we scrutinized the variant allele frequency (VAF) distribution of somatic 
mutations in each age group. Overall, variant allele frequencies of non-synonymous mutations 
significantly increased in epidermal samples from elderly donors compared to those collected 
from young donors (Wilcoxon-Mann-Whitney test, P-value = 8.30x10-8; Figure 5E), suggesting 
tolerance and selection for larger clones with age. 
 
To further quantify whether non-synonymous mutations had an appreciably impact on cell 
fitness, we compared the sizes of clones carrying non-synonymous mutations to those with 
synonymous mutations. The average VAF of non-synonymous mutations per gene was 
significantly higher than that of synonymous mutations in normal skin samples from both young 
(Wilcoxon-Mann-Whitney test, P-value = 9.96x10-6) and elderly donors (Wilcoxon-Mann-
Whitney test, P-value = 6.21x10-8; Figure 5E). The highest average VAF was observed in 
cancer-associated genes under positive selection (NOTCH1, FAT1 and TP53), suggesting that 
these selectively advantageous mutations may appear early and expand with age in sun-exposed 
normal skin. However, the relative low frequency of somatic mutations also pointed out that 
they are present in only a small subset of skin cells, therefore remaining in a minority of sun-
exposed cells.  
 
A high number of sun-exposed samples (79.67%) carried at least one non-synonymous mutation 
in a cancer gene under positive selection (TP53, NOTCH1, and FAT1). Contrary to our 
expectation, no differences in the distribution of VAF (normalized by the average VAF of all 
other detected mutations per sample) were found when comparing skin samples carrying only 
one mutation with those carrying multiple different mutations in one of the three positively 
selected genes (Figure S5A). Therefore, together with findings previously found, clone size 
seems to be closely related to age. Consistent with previous findings (Yizhak et al., 2019), 
samples harbouring mutations in TP53, NOTCH1 and FAT1, as well as other canonical hotspot 
mutations, had a significant increase in the overall number of mutations. Although this increase 
seems to be largely influenced by the participant’s age, mutation count was age-independently 
associated with carrying protein-altering mutations in these positively selected genes (Figure 
S5B).  
 
Taken as a whole, our data suggest that protein-affecting mutations in 5 of the 46 sequenced 
genes (TP53, NOCTH1, FAT1, NOTCH2 and CDKN2A) are subject to statistically significant 
positive selection. Furthermore, we find that skin from elderly individuals not only harbours 
more mutations, but a larger fraction of these reflects positive selection. We speculate that the 
majority of the cells carrying driver mutations may not have yet acquired the right combination 
of mutated genes for expanding and culminating in the development of malignancy. In this 
regard, although recurrently mutated genes were similar between normal and cSCC samples, the 
distribution of variant frequencies in normal skin was significantly lower than the one observed 




Like other tissues, skin undergoes chronological aging that might lead to its functional decline, 
which is accelerated by chronic sun damage. This study aimed to explore the role of photoaging, 
as well as other well-known epidemiological risk factors, in the accumulation of somatic 
mutations in cancer-free human epidermis. Our experimental design was focused on analysing 
the mutational landscape in a large cohort of subjects with a wide range of ages and phenotypic 
characteristics. 
 
A profound variability in terms of mutational burden and driver mutations was observed among 
individuals. This variability was largely explained by age; on average 3.25 mutations/Mb were 
acquired in the panel of 46 genes per year of life. In addition, normal skin samples collected 
from donors with low skin phototypes (individuals with fair skin who tend to burn rather than 
tan after being exposed to sunlight) tended to accumulate a higher number of somatic mutations 
over time. Fair-skinned individuals are more severely affected by photoaging (Fisher et al., 
2002). Therefore, the increased risk of developing skin cancer, at least for sporadic cancers, 
associated with these phenotypes may be due to the presence of a higher reservoir of mutant 
cells waiting to acquire more cancer-driving mutations, evade clonal growth control and initiate 
malignant transformation. By contrast, sun exposure habits were not significantly correlated to 
mutational burden variability across samples. Note that our samples are collected from Spanish 
individuals living in a region with relatively high UV index and pleasant weather throughout the 
year. Perhaps a higher effect of sun exposure pattern by body site would be found in populations 
from more northerly latitudes, exposed to sunlight mainly during summer vacations. 
Furthermore, the retrospective and subjective nature of some behavioural risk factors, 
particularly those related to sun exposure habits, raises the potential for recall bias. Therefore, 
validation in independent and larger cohorts will be needed to further analyse the association 
between behavioural risk factors and mutation burden. 
 
Analysing a large cohort with a wide age range has allowed us to investigate the timing of 
somatic mutation accumulation in normal skin. Nearly all T>C mutations are accumulated early 
in life, as the number of these mutations accumulated in normal skin from young and elderly 
donors is similar. In contrast, an exponential rise of UV-related mutations with increasing age 
was evident in normal epidermis. This exponential increase of UV-related mutations, together 
with the fact that these mutations are mainly accumulated in the coding strand, could be related 
to the decline of nucleotide excision repair (NER) capacity with increasing age (Gorbunova et 
al., 2007). NER is a highly evolutionarily conserved mechanism for repairing bulky DNA 
lesions resulting, among others, from sunlight exposure. The importance of NER activity in the 
prevention of skin cancer is denoted by the extreme sensitivity to sunlight and severe 
predisposition to UV-induced skin cancers of patients with the inherited disorder xeroderma 
pigmentosum, in which genes encoding for the different components of the NER cascade are 
mutated (Lehmann et al., 2018).  
 
Remarkably, the age-dependent exponential increase of skin cancer incidence in Spain 
recapitulates the accumulation of UV-related mutations in normal skin. Apart from the decline 
of NER function, skin photoaging has also been linked to impaired skin homeostasis (Panich et 
al., 2016). It is thought that strategies for tissue maintenance have a noteworthy impact on 
cancer incidence, consistent with the dramatic increase of cancer incidence with tissue and stem 
cell fitness decline (Rozhok and DeGregori, 2016). Aged/damaged tissue microenvironment 
may therefore provide an opportunity for clones with a selective advantage to expand, and that 
may be the reason why mutational profile notably differs between normal skin samples from 
young and adult donors. 
 
Our results revealed an enrichment of driver mutations in the majority of normal sun-exposed 
skin samples, especially in those collected from elderly individuals. In addition, there is a 
marked overrepresentation of protein-altering mutations in several cSCC driver genes, 
especially in NOTCH1, TP53 and FAT1, likely reflecting positive selection. However, because 
these genes have been shown to be frequently mutated in normal skin (Martincorena et al., 
2015; Yizhak et al., 2019), it seems unlikely that these mutations alone confer a sufficient 
growth advantage to engender cancer development. Indeed, although clones carrying these 
selectively advantageous mutations have expanded in normal skin, it is notable that only 21 out 
of 127 donors (16.53%) carried more than one mutation with clinical relevance in their skin. 
These mutant clones also seem to be relatively small, suggesting even in these cases the somatic 
alterations are often in distinct clones.  
 
Cellular senescence, an irreversible proliferative arrest triggered by exogenous and endogenous 
stresses, may be a plausible explanation for the limited expansion of clones carrying cancer-
causing mutations in normal tissues. Oncogenic-induced senescence is considered a crucial 
protective mechanism against cell transformation. Several reports from animal models support 
the idea that cell senescence may occur in tissues after acquiring a mitogenic mutation, 
preventing carcinogenesis at as initial step (Braig et al., 2005; Collado et al., 2005). The biology 
of naevi is a clear example of cellular senescence following an initial activating oncogenic 
mutation, normally in BRAF or NRAS genes (Bennett, 2003; Bennett and Medrano, 2002). 
Melanocytic nevi are clonal proliferations of non-malignant melanocytic cells, which can 
remain non-growing for many years, but also can act as precursors of melanoma if cells 
overcome senescence. Interventions that favour oncogene-induced senescence may help restrict 
the growth of clones carrying cancer-causing mutations in normal tissues and thus tumour 
progression.  
 
The question arising from our observations, together with those shown in different sequencing 
studies previously performed on healthy tissues (Brunner et al., 2019; Jaiswal et al., 2014; Lee-
Six et al., 2019; Martincorena et al., 2015, 2018; Suda et al., 2018), is whether or not targeting 
these early mutations recurrently found in normal tissues will be relevant for preventing 
carcinogenesis. Further efforts should be done to delineate the succession of genetic alterations 
needed for malignant transformation of physiologically normal tissues to premalignant 
precursor lesions, and finally to tumours, with the aim of discriminating drivers of the disease 
from the non-pathogenic mutational landscape. Regarding skin cancers, studying the 
mechanism of clonal evolution in normal skin offers the possibility to develop strategies for 
early detection and treatment of putative tumorigenic clones, but also for prevention of skin 








A total of 127 cancer-free volunteers donated a normal skin sample obtained from the margin of 
skin excision biopsies undertaken to remove a cutaneous benign lesion (Table S1). Four 
samples were collected from non-photoexposed skin areas (gluteus and armpit), 79 samples 
were collected from skin areas with intermittent sun exposure (back, chest, legs and upper 
arms), and 44 samples were obtained from chronically sun-exposed skin areas (neck, face and 
hands). Samples were recruited at the Department of Dermatology of two hospitals from 
Castellon Province, Spain (Castellon University General Hospital and La Plana University 
Hospital). Only one sample was recruited per donor due to ethical reasons. All participants 
provided a written informed consent. The study was approved by the Ethics Committee of the 
Jaume I University of Castellon (Spain).  
 
Immediately after resection, tissue samples were submerged in RNAlater Tissue Collection 
Solution (Thermo Fisher Scientific, Walham, MA, USA) and stored at 4ºC overnight. Then, the 
epidermis was separated from the dermis by incubating the tissue sample in 3.8% ammonium 
thiocyanate (Sigma-Aldrich, St Louis, MO, USA) in PBS (pH 7.4) at room temperature for 3 
hours. Subsequently, the epidermis was immersed in RNAlater solution and stored at -20ºC 
until sample processing. 
 
Genomic DNA was isolated from fresh-frozen normal epidermal samples with the QIAamp 
DNA Mini Kit, (Qiagen, Hilden, Germany). DNA was stored at -20ºC until use. 
 
Phenotypic data collection 
 
Each participant completed a standardised questionnaire to collect information on sex, age, 
pigmentation traits (skin, hair and eye colour), skin sensitivity to sunlight (tanning ability versus 
tendency to burn), freckling degree, history of childhood sunburns, and sun exposure habits. 
Pigmentation- and sun sensitivity-related traits were used to group individuals according to 
Fitzpatrick’s skin type classification. Detailed information related to signs of sun damage in the 
skin area biopsied (pigmented spots, blotches, and wrinkles) was also recorded. To avoid 
misclassification, each participant completed the questionnaire under the supervision of a 
professional. 
 
Sequencing of MC1R coding region 
 
The coding sequence of the MC1R gene was directly sequenced in all samples, as previously 
described (Martínez-Cadenas et al., 2013). Non-synonymous MC1R mutations were then 
defined as ‘R’, ‘r’ or ‘p’ (pseudoallele) alleles according to their impact on protein function, 
following criteria previously described (Hernando et al., 2018).  
 
Ultra-deep targeting sequencing 
 
A panel of 46 genes was chosen to perform ultra-deep targeted sequencing. These genes have 
been found to be often involved in skin cancer development (Hayward et al., 2017; Inman et al., 
2018; Jayaraman et al., 2014) and/or have been shown to be frequently mutated in normal skin 
samples (Martincorena et al., 2015). A custom bait capture was designed using NimbleGen 
SeqCap EZ (Roche, Basel, Switzerland) in order to target the exonic regions of the selected 
genes. The total size of the targeted regions was 0.32 Mb.  
 
Sequencing of paired-end 100bp reads was performed on an Illumina HiSeq 2000 machine. The 
average on-target coverage across samples was 953.82x, ranging from 377.96x to 1657.37x. 
The variation in coverage across genes and samples is displayed in Figure S6. Note that the 
mutation burden found per gene, as well as per sample, was not strongly influenced by 
differences in coverage (Figure S6C). 
 
Paired-end reads were aligned to the reference human genome (GRCh37d5) using the BWA-
MEM algorithm with default parameters (Li and Durbin, 2009). Alignment files (BAM format) 
containing only properly paired, uniquely mapping reads were processed using Picard tools 
version 1.110 (http://broadinstitute.github.io/picard/) to add read groups and remove PCR 
duplicates. Local realignments and base-quality recalibrations were conducted using GATK 




Processed BAM files were analysed to identify single-nucleotide variants (SNVs) and small 
insertions and deletions (indels). Somatic mutations are normally called by detecting 
mismatches present in a tissue sample that are absent in a matched control sample (normal 
tissue or blood from the same patient). Due to the absence of matched normal sample from each 
individual, processed BAM files were used to perform somatic variant calling by applying 
Mutect2 in tumour-only mode (version 4.0.8.1). Following Broad Institute recommendations for 
variant calling, putative artefacts were removed with FilterMutectCalls and 
FilterByOrientationBias. We provided FilterMutectCalls the set of human variants from 
gnomAD (https://gnomad.broadinstitute.org). Functional annotations were added to the 
resulting list of variants using SnpEff (Cingolani et al., 2012a), with the gene annotation based 
on Ensembl data release 75. Variants were then annotated using SnpSift (Cingolani et al., 
2012b), with population frequencies, conservation scores and deleteriousness predictions 
obtained from dbNSFP (Liu et al., 2013). Each variant was also annotated using gnomAD, 
COSMIC, ExAC, and ClinVar. 
 
Then, a number of post-processing filters were applied. Firstly, we focused on identifying and 
removing germline variants. The variant caller Platypus was used to identify germline variants, 
which were filtered out from the list of somatic mutations (Rimmer et al., 2014). The tool was 
run using the human variant set from dbSNP as the reference, instead of using a matched normal 
sample. Mutations detected in each sample were additionally called against the aggregate 
variants from a panel of normal samples of 200 Spanish individuals sequenced in the facilities 
of the CNAG-CRG (Barcelona, Spain) in order to remove common single-nucleotide 
polymorphisms (SNPs) and frequent technical artefacts. Indeed, variants were filtered out if 
they appeared in any of the ExAC, 1000 Genomes Project and dbSNP databases. As our 
filtering strategy seems to be quite rigorous, we decided to not remove those mutations that are 
included in the catalogue of somatic mutations found in human cancers (according to COSMIC 
and DoCM databases) for downstream analyses. These 75 putative driver mutations had a low 
VAF (mean = 0.021, max = 0.093) and prevalence (mean = 1.42%, max = 2.74%) in our cohort. 
To reduce false positive calls, variants were also filtered out based on their allele frequency. Our 
study was designed to detect mutations present in a small fraction of the skin cells of the biopsy. 
Variant allele frequencies for somatic mutations in normal samples are more likely to have 
values below 50%, as shown previously in normal skin samples from eyelids (Martincorena et 
al., 2015). Therefore, we filtered out a variant when the 95% confidence intervals (CIs) of its 
VAF (determined by the binomial distribution taking into account the depth of coverage) 
reached values greater than 50%. To increase the sensitivity of our analyses, we also opted to 
remove all variants present with VAF values two standard deviations away from the mean per 
sample. As we were working with a small cohort of unrelated patients, mutations with a 
prevalence higher than 25% in our cohort were further excluded. Next, we also excluded 
variants that have not been found to have a clinical relevance in human cancers (according to 
DoCM database) with a prevalence two standard deviations away from the mean of our cohort. 
That is because spontaneously-arising neutral mutations are extremely unlikely to affect 
samples collected from different patients. Finally, sites with very low coverage (n<50 reads) 
were also excluded to avoid testing sites with limited power to detect variants.  
To check if the majority of mutations removed were germline variants or technical artefacts, we 
studied the context-specific mutation spectra for each set of mutations removed at each filtering 
step (Figure S1A). Note that the majority of substitutions removed were not related to UV 
damage (C>T mutations at dipyrimidine sites). Indeed, having a global dN/dS ratio << 1 may 
denote that the pre-filtering dataset of variants is contaminated with germline SNPs (Figure 
S1B). 
 
Prediction of mutational burden 
 
A log-linear model was applied to correlate the number of mutations detected per sample with 
the sun exposure pattern of the skin sample and the individual’s age, including different 
phenotypic traits as covariates. The covariates included in the model were sex (female vs. male), 
skin phototypes (I vs. II, III or IV), sun damage in the tissue (absence vs. presence), history of 
sunlight exposure (frequently vs. occasionally), and MC1R genotype (wild-type vs. r carriers or 
R carriers). The R package ‘relaimpo’ was used to assess the relative importance of the different 
variables included in the model. Non-photoexposed skin samples were excluded in this analysis 
due to the reduced sample size of this group (n=4). Nonparametric bootstraps (1000 runs) were 
conducted to estimate the 95% confidence intervals (CI95) of the age effect in each skin 
phototype subgroup. 
 
In order to double-check that the majority of mutations were real somatic variants, we applied 
the log-linear model using the pre-filtering dataset of variants (Figure S1C). Note that the total 
variance of mutational burden explained by the model was very low (adjusted-R2 = 6.08%), and 
the major predictors of mutational burden were completely different than those obtained when 
the filtering mutation dataset was used.  
 
Analysis of local mutational context and extraction of mutational signatures 
 
Mutational spectrum and signatures analyses were performed by using the deconstructSigs R 
package (Rosenthal et al., 2016). Due to the limited number of mutations found in some 
samples (less than 50 mutations), we decided to group the samples by (a) age of individuals, and 
(b) pattern of sunlight exposure of skin tissue biopsied. Firstly, the proportion of each distinct 
single base substitution, as well as of each dinucleotide mutation, occurring within a given 
trinucleotide context was determined per each sample and per group. Hierarchical clustering of 
samples based on trinucleotide context of mutations was performed by applying the Ward's 
criterion. Samples were mainly divided into the different clusters by age and body site exposure, 
confirming that the vast majority of mutations included in our final list are real somatic 
mutations (Figure S2A).  
 
Then, we evaluated the transcriptional strand bias for the mutations that are located within 
exons. A Poisson test was applied to assess whether the mutations occurred more often in the 
transcribed or untranscribed strand, or vice versa. Exon definitions for human reference genome 
were retrieved from BiomaRt by loading a TxDb annotation package from Bioconductor 
(Durinck et al., 2005). 
 
The limited number of variants hampers the discovery of new mutational signatures. Therefore, 
we ran deconstructSigs including only the mutational signatures related to aging and/or 
previously observed in the different skin cancers subtypes that contribute at least 6% of all of 
the observed mutations across the 127 samples (SBS2, SBS6, SBS7a, SBS7b, SBS7d, and 
SBS17a). Figure S2B shows the weights assigned to all of these mutational signatures for the 
combined set of mutations within cohort (Total) and per age group. Due to the limited number 
of samples and the low number of mutations, non-photoexposed skin samples were excluded. 
 
Prevalence of non-synonymous mutations and selection analyses 
 
Selection across the normal skin samples was quantified by using the dNdScv R package 
(Martincorena et al., 2017), which adapts the traditional implementation of dNdS ratio by using 
trinucleotide context-dependent substitution models to avoid common mutation biases affecting 
dN/dS. Selection tests were performed on different subsets of mutations by grouping samples 
per age. Briefly, global and gene-level dNdS ratios were quantified for missense and truncating 
(nonsense and essential splicing) mutations, as well as for indels, and then were used to 
compare the selection intensities between skin samples biopsied from elderly and young 
individuals. Again, the fact that our results reveal an excess of non-synonymous mutations 
(dNdS > 1), especially in genes frequently involved in skin cancer development, suggests that 
our list of mutations is not contaminated by germline variants or technical artefacts (Figure 5C).  
 
The database of curated mutations (DoCM, docm.genome.wustl.edu) was used to identify 
canonical hotspot mutations with characterized functional or clinical evidence in cancer. 
 
Identification of frequently mutated genes in skin cancer  
 
The dNdS package was also applied to detect recurrently mutated genes in publicly available 
skin cancer mutation calls of 40 cutaneous squamous cell carcinomas (Inman et al., 2018) and 
140 cutaneous melanomas (Hayward et al., 2017). Then, the mutational landscape in skin cancer 
samples was compared to the observed in our dataset of normal skin samples. The analysis was 
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Figure 1. Schematic overview of the experimental design. 
 
Figure 2. Somatic mutation burden in normal epidermis. (A) Total number and type of 
somatic mutations detected across the 46 genes sequenced in each sample. Clinical and 
demographic characteristics are presented below. (B) Correlation between donor age and the 
number of somatic mutations accumulated in the donor’s sample. The fitted line, confidence 
interval, correlation coefficient (ρ), and P-value were obtained by performing a Spearman’s 
correlation test. (C) Differences in the number of somatic mutations of normal epidermal 
samples according to the sunlight exposure pattern of body site from which the sample was 
resected. A Kruskal-Wallis test is used for testing differences among groups, and a Wilcoxon-
Mann-Whitney test is used as a post-hoc test for performing pairwise comparisons.  
 
Figure 3. Linear modelling of the accumulation of somatic mutations in normal epidermis. 
(A) Relative importance of predictors included in the log-linear regression model. The total 
variance explained by the model (adjusted-R2 = 49.88%) is decomposed in order to know the 
individual contribution (effect size) of each predictor. Asterisk denotes significant predictors. 
(B) A log-linear regression is used for analysing the age effect in the accumulation of somatic 
mutations for each skin phototype. Solid lines represent the bootstrapped mean of the slope, and 
shaded areas its bootstrapped 95% confidence intervals (CI95). 
 
Figure 4. Spectrum of somatic mutations in normal epidermis. (A) Bar plot showing the 
fraction of single (top) and doublet (bottom) base substitutions found in each of the possible 96 
trinucleotide context (strand independent). (B) Relative number of each substitution type 
present on the transcribed (dark shading) and untranscribed strand (light shading). Asterisks 
indicate significant transcriptional strand asymmetries (Poisson test). (C) Mutational spectra in 
samples from young (left) and elderly donors (right). Heatmaps show the fraction of each 
trinucleotide change in each sample (middle). Bar plots represent the contribution mean of each 
96-mutation type per age group (top). Clinical and demographic characteristics are presented 
next to each sample (right). (D) Age-dependent increase of both UV-mutation accumulation and 
skin cancer incidence. Data of skin cancer incidence in Spain was downloaded from the Global 
Cancer Observatory (http://gco.iarc.fr). 
 
Figure 5. Positive selection and expansion of driver mutations in normal skin with age. (A) 
Number of mutations detected per sample. Dots are coloured according to donor’s age. A 
Wilcoxon-Mann-Whitney test is used for testing differences among groups. (B) Number of 
mutations detected per gene normalized by sample size of the respective group. A Wilcoxon-
Mann-Whitney test is used for testing differences among groups. (C) Global dN/dS values 
estimated by taking together all 46 genes in normal skin biopsied from both young and elderly 
donors. Error bars represent 95% confidence intervals. (D) dN/dS ratios for each of the 46 target 
genes. Genes under significant positive selection in both age groups are coloured in red, while 
genes positively selected only in the elderly group are coloured in blue (overall q-value < 0.05). 
Genes are sorted from higher (bottom) to lower (top) significant value in the elderly group. (E) 
Distribution of VAFs of somatic non-synonymous and synonymous mutations per gene. Red 
dots denote positively selected genes in both young and elderly groups (FAT1, NOTCH1, and 
TP53), and blue dots indicate genes under positive selection only in the elderly group (NOTCH2 
and CDKN2A). Dots representing the other genes sequenced are coloured in grey. A Wilcoxon-
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Figure S1. Evaluation of variant calling and filtering, Related to Figures 2 to 5. (A) Spectra 
of mutation sets removed after applying a specific filtering step. All mutational spectra are very 
different from the typical UV-related mutational spectrum, indicating that the filtered variants 
are unlikely to be real somatic mutations. (B) Global dN/dS ratios estimated before and after 
mutation filtering called with Mutect2 tumour-only mode. The global dN/dS << 1 denotes 
contamination of germline variants and/or technical artefacts in the non-filtered dataset of 
somatic mutations. This problem seems to be solved after applying the different filtering steps 
(dN/dS > 1). Error bars denote 95% confidence interval. (C) Results of applying a log-linear 
regression model in the non-filtered mutation dataset for predicting the number of mutations per 
sample. The low variance explained by the model (adjusted-R2 = 6.08%) denotes that the non-
filtered list of mutations includes a large number of likely false positive calls. (D) Histogram of 
somatic mutations identified by variant allele frequency (VAF). Most somatic mutations remain 
in a subclonal state with low VAFs (VAF << 5%). 
 
Figure S2. Mutational spectra in normal skin, Related to Figure 4. (A) Heatmap showing 
the fraction of each 96-mutation type per sample. Clinical and demographic characteristics are 
presented above each sample. (B) Percentage of substitutions attributed to each one of the six 
mutational signatures for all mutations from all 127 samples together (Total), as well as for all 
mutations included in each age subgroup.  
 
Figure S3. Age-related mutational spectra in normal skin, Related to Figure 4. (A) Local 
mutational context of T>C substitutions in samples biopsied from young and elderly donors. (B) 
Relative number of each substitution type present on the transcribed (dark shading) and 
untranscribed strand (light shading) in samples biopsied from young and elderly donors. 
Asterisks indicate significant transcriptional strand asymmetries (Poisson test). (C) 96-barplot 
depicting the number of mutations observed at each trinucleotide context taking together all 
samples biopsied from young and elderly individuals (Total), as well as splitting samples of 
each age group by the body site pattern of sun exposure (Chronically- and Intermittently-
photoexposed). 
 
Figure S4. Occurrences of somatic mutations in the 46 cancer genes across samples, 
Related to Figure 5. (A) Heatmap showing the distribution of recurrent non-synonymous 
mutations per coding kilobase of sequence for each one of the 46 genes targeted across all 
normal skin samples. Clinical and demographic characteristics are presented above each sample. 
The KMT2B gene is not included in this plot since no non-synonymous mutation was found 
across samples. (B) Percentage of normal skin samples, as well as in cSCC and melanoma 
tumours, carrying at least one non-synonymous mutation in each gene.  
 
Figure S5. Clonal expansion of clones with oncogenic mutations, Related to Figure 5. (A) 
Distribution of VAFs for NOTCH1, TP53 and FAT1 in normal skin samples carrying only one 
or multiple mutations in the respective gene. For samples with multiple mutations in one of 
these three genes, the mean VAF for all mutations per gene is plotted. Each dot represents a 
sample and is coloured according to the donor’s age. In each panel, a Wilcoxon-Mann-Whitney 
test is used for testing differences among groups. (B) Number of non-synonymous mutations 
per sample in normal skin samples non-carriers or carriers of one or multiple non-synonymous 
mutations in NOTCH1, TP53 and FAT1, as well as in normal skin without or with canonical 
hotspot mutations. Each dot represents a sample and is coloured according to the donor’s age. 
For avoiding the confounding effects of age, samples were stratified according to donor’s age 
for statistical analyses. In panels comparing more than two groups, a Kruskall-Wallis (KW) test 
is used for testing differences among groups. In panels comparing two groups, a Wilcoxon-
Mann-Whitney (WMW) test is used for testing differences among groups. (C) Heatmap 
showing the mean VAF of all non-synonymous mutations found per gene across all normal, 
cSCC and melanoma samples. 
 
Figure S6. Coverage and mutational burden across genes and samples, Related to Figures 
2 to 5. (A) Plot showing the number of mutations per gene across all samples (bar plot, top) and 
the mean coverage per gene and sample (box plot, bottom). Genes in the x-axis sorted by mean 
coverage across samples. Blue line indicates the mean coverage across all samples. (B) Plot 
showing the number of mutations per sample (bar plot, top) and the mean coverage per sample 
(bar plot, bottom). Samples in the x-axis sorted by mean coverage across all sequenced regions. 
Blue line indicates the mean coverage across all samples. (C) Scatter plots showing the 
coverage and number of mutations per gene (left) and per sample (right). These plots show that 
coverage did not significantly influence the number of mutations found across genes and/or 
across samples. 
 
Table S1. Demographic and clinical data of all Spanish donors, Related to Figures 1 to 5. 
 
Table S2. Log-linear modelling of the accumulation of somatic mutations in normal skin, 
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Figure S1. Evaluation of variant calling and filtering, Related to Figures 2 to 5. (A) Spectra 
of mutation sets removed after applying a specific filtering step. All mutational spectra are very 
different from the typical UV-related mutational spectrum, indicating that the filtered variants 
are unlikely to be real somatic mutations. (B) Global dN/dS ratios estimated before and after 
mutation filtering called with Mutect2 tumour-only mode. The global dN/dS << 1 denotes 
contamination of germline variants and/or technical artefacts in the non-filtered dataset of 
somatic mutations. This problem seems to be solved after applying the different filtering steps 
(dN/dS > 1). Error bars denote 95% confidence interval. (C) Results of applying a log-linear 
regression model in the non-filtered mutation dataset for predicting the number of mutations per 
sample. The low variance explained by the model (adjusted-R2 = 6.08%) denotes that the non-
filtered list of mutations includes a large number of likely false positive calls. (D) Histogram of 
somatic mutations identified by variant allele frequency (VAF). Most somatic mutations remain 






Figure S2. Mutational spectra in normal skin, Related to Figure 4. (A) Heatmap showing 
the fraction of each 96-mutation type per sample. Clinical and demographic characteristics are 
presented above each sample. (B) Percentage of substitutions attributed to each one of the six 
mutational signatures for all mutations from all 127 samples together (Total), as well as for all 






Figure S3. Age-related mutational spectra in normal skin, Related to Figure 4. (A) Local 
mutational context of T>C substitutions in samples biopsied from young and elderly donors. (B) 
Relative number of each substitution type present on the transcribed (dark shading) and 
untranscribed strand (light shading) in samples biopsied from young and elderly donors. 
Asterisks indicate significant transcriptional strand asymmetries (Poisson test). (C) 96-barplot 
depicting the number of mutations observed at each trinucleotide context taking together all 
samples biopsied from young and elderly individuals (Total), as well as splitting samples of 






Figure S4. Occurrences of somatic mutations in the 46 cancer genes across samples, 
Related to Figure 5. (A) Heatmap showing the distribution of recurrent non-synonymous 
mutations per coding kilobase of sequence for each one of the 46 genes targeted across all 
normal skin samples. Clinical and demographic characteristics are presented above each sample. 
The KMT2B gene is not included in this plot since no non-synonymous mutation was found 
across samples. (B) Percentage of normal skin samples, as well as in cSCC and melanoma 






Figure S5. Clonal expansion of clones with oncogenic mutations, Related to Figure 5. (A) 
Distribution of VAFs for NOTCH1, TP53 and FAT1 in normal skin samples carrying only one 
or multiple mutations in the respective gene. For samples with multiple mutations in one of 
these three genes, the mean VAF for all mutations per gene is plotted. Each dot represents a 
sample and is coloured according to the donor’s age. In each panel, a Wilcoxon-Mann-Whitney 
test is used for testing differences among groups. (B) Number of non-synonymous mutations 
per sample in normal skin samples non-carriers or carriers of one or multiple non-synonymous 
mutations in NOTCH1, TP53 and FAT1, as well as in normal skin without or with canonical 
hotspot mutations. Each dot represents a sample and is coloured according to the donor’s age. 
For avoiding the confounding effects of age, samples were stratified according to donor’s age 
for statistical analyses. In panels comparing more than two groups, a Kruskall-Wallis (KW) test 
is used for testing differences among groups. In panels comparing two groups, a Wilcoxon-
Mann-Whitney (WMW) test is used for testing differences among groups. (C) Heatmap 
showing the mean VAF of all non-synonymous mutations found per gene across all normal, 






Figure S6. Coverage and mutational burden across genes and samples, Related to Figures 
2 to 5. (A) Plot showing the number of mutations per gene across all samples (bar plot, top) and 
the mean coverage per gene and sample (box plot, bottom). Genes in the x-axis sorted by mean 
coverage across samples. Blue line indicates the mean coverage across all samples. (B) Plot 
showing the number of mutations per sample (bar plot, top) and the mean coverage per sample 
(bar plot, bottom). Samples in the x-axis sorted by mean coverage across all sequenced regions. 
Blue line indicates the mean coverage across all samples. (C) Scatter plots showing the 
coverage and number of mutations per gene (left) and per sample (right). These plots show that 







Table S1. Demographic and clinical data of all Spanish donors, Related to Figures 1 to 5. 
 
  Pattern of sunlight exposure of normal skin samples   
  Chronic 
(N = 44) 
Intermittent 
(N = 79) 
Unexposed 
(N = 4) 
Total 
(N = 127) 
  Mean SD Mean SD Mean SD Mean SD 
Age (years)   69.86 15.99 52.16 20.91 45.00 30.32 58.07 21.35  
                
    N % N % N % N % 
Sex Females 12 27.27 47 59.49 2 50.00 61 48.03 
Males 32 72.73 32 40.51 2 50.00 66 51.97 
Unknown 0 0.00 0 0.00 0 0.00 0 0.00 
Fitzpatrick skin 
type ‡ 
I 3 6.82 11 13.92 1 25.00 15 11.81 
II 13 29.55 34 43.04 3 75.00 50 39.37 
III 21 47.73 25 31.65 0 0.00 46 36.22 
IV 6 13.64 9 11.39 0 0.00 15 11.81 
Unknown 1 2.27 0 0.00 0 0.00 1 0.79 
MC1R genotype Wild-type 18 40.91 28 35.44 3 75.00 49 38.58 
r carrier 18 40.91 26 32.91 0 0.00 44 34.65 
R carrier 7 15.91 22 27.85 1 25.00 30 23.62 
Unknown 1 2.27 3 3.80 0 0.00 4 3.15 
History of sun 
exposure ¥ 
Occasional 18 40.91 54 68.35 4 2.17 76 59.84 
Frequent 22 50.00 21 26.58 0 0.00 43 33.86 
Unknown 4 9.09 4 5.06 0 97.83 8 6.30 
Sun damage in 
the skin area 
No 6 13.64 46 58.23 3 2.17 55 43.31 
Yes 35 79.55 27 34.18 0 0.00 62 48.82 
Unknown 3 6.82 6 7.59 1 97.83 10 7.87 
N, number of individuals; %, percentage of individuals per group among the total 
‡ Fitzpatrick’s skin type classification is based on pigmentation traits (skin, hair and eye colour) and sun sensitivity-
related traits (ability to tan versus tendency to burn, and freckling degree) 





Table S2. Log-linear modelling of the accumulation of somatic mutations in normal skin, 
Related to Figure 3 
 
Variable Categories β SE P-value ‡ R2 (%) 
Age  0.028 0.004 1.46E-09 55.17 
Sex Female reference - - 3.89 
  Male -0.109 0.165 0.51   
Sunlight exposure 
of body site 
Chronic reference - - 7.83 
Intermittent -0.171 0.179 0.34   
Sun damage No reference - - 7.95 
  Yes 0.187 0.168 0.27   
Skin phototype I reference - - 17.93 
 II -0.387 0.266 0.11   
 III -0.414 0.253 0.15   
 IV -1.220 0.312 1.74E-04   
MC1R genotype wild-type reference - - 2.00 
  r carrier 0.104 0.180 0.56   
  R carrier -0.226 0.191 0.24   
History of sunlight 
exposure 
Frequent reference - - 5.23 
Occasional -0.189 0.161 0.24   
β, coefficients; SE, standard error; R2, percentage of relative contribution of each predictor to 
the total variance 
‡ P-value for the multivariate log-linear model 
 
 
 
 
 
